XENE
NASDAQ · Biotechnology
Xenon Pharmaceuticals Inc
$54.79
+1.88 (+3.55%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+22.19%
1Y
+73.99%
YTD
+23.15%
Open$52.91
Previous Close$52.91
Day High$55.59
Day Low$52.91
52W High$63.95
52W Low$30.00
Volume—
Avg Volume1.30M
Market Cap5.11B
P/E Ratio—
EPS$-4.70
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$42.54
Above
SMA 200
$37.78
Above
RSI (14)
57.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
26 analysts
Price Target
-63.5% upside
Current
$54.79
$54.79
Target
$19.98
$19.98
$12.55
$19.98 avg
$22.13
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.14M | 9.87M | 1.14B |
| Net Income | -421,906,438 | -409,838,957 | -213,860,892 |
| Profit Margin | -4,612.1% | -4,381.5% | -18.8% |
| EBITDA | -451,930,757 | -463,393,652 | -248,558,556 |
| Free Cash Flow | — | — | -268,893,932 |
| Rev Growth | -7.4% | -7.4% | +15.1% |
| Debt/Equity | — | — | 0.33 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $230.01 | +6.25% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $344.72 | +2.11% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $124.87 | +0.90% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $466.79 | +3.36% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $612.50 | +0.42% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.41 | +2.99% | 64.3 | 37.13B |